APA

Huang V. W., Prosser C., Kroeker K. I., Wang H., Shalapay C., Dhami N., Fedorak D. K., Halloran B., Dieleman L. A., Goodman K. J. & Fedorak R. N. (20160211). Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. : Inflammatory bowel diseases.

Chicago

Huang Vivian W, Prosser Connie, Kroeker Karen I, Wang Haili, Shalapay Carol, Dhami Neil, Fedorak Darryl K, Halloran Brendan, Dieleman Levinus A, Goodman Karen J and Fedorak Richard N. 20160211. Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. : Inflammatory bowel diseases.

Harvard

Huang V. W., Prosser C., Kroeker K. I., Wang H., Shalapay C., Dhami N., Fedorak D. K., Halloran B., Dieleman L. A., Goodman K. J. and Fedorak R. N. (20160211). Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. : Inflammatory bowel diseases.

MLA

Huang Vivian W, Prosser Connie, Kroeker Karen I, Wang Haili, Shalapay Carol, Dhami Neil, Fedorak Darryl K, Halloran Brendan, Dieleman Levinus A, Goodman Karen J and Fedorak Richard N. Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy. : Inflammatory bowel diseases. 20160211.